dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments India's Dr plans to launch generic obesity drugs in 87 countries next year, CEO says Advances in GLP-1 receptor agonists – How GLP-1 Receptor Agonists Evolved

dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments

dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments India's Dr plans to launch generic obesity drugs in 87 countries next year, CEO says Advances in GLP-1 receptor agonists – How GLP-1 Receptor Agonists Evolved

Name: dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments India's Dr plans to launch generic obesity drugs in 87 countries next year, CEO says Advances in GLP-1 receptor agonists – How GLP-1 Receptor Agonists Evolved
Brand: wefit.es
SKU: 50520906332
Price: 26.09 USD
Availability: InStock
Rating: 4.8361 (25 reviews)

SKU: 50520906332

4.8

USD26.09 USD76.09

Pay in 4 interest-free payments of $6.52 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

A randomised placebo-controlled trial (RCT) including 42 participants with schizophrenia, who were experiencing an acute phase of symptomatology, were randomly assigned to receive up to 2 g/d of NAC plus up to 6 mg/d of risperidone for 8 weeks as an adjunct intervention